Drug intelligence / Profile preview

2-methylthioadenosine 5'-diphosphate

Development stage
Preclinical
Modality
Small Molecules
Administration
Inhalation, Intravenous
01

Overview

2-methylthioadenosine 5'-diphosphate (2Me-SADP) is a potent nucleotide analog that serves as an agonist for several P2Y purinergic receptors, most notably the P2Y1, P2Y12, and P2Y13 subtypes. It is widely utilized as a pharmacological research tool to investigate purinergic signaling pathways involved in platelet aggregation, neurotransmission, and vascular tone regulation. In experimental models of pulmonary hypertension, 2Me-SADP has been evaluated for its potential vasodilatory properties, although studies in rat arterial tissues have demonstrated relatively low maximal efficacy compared to other vasodilators like sildenafil or riociguat. It is primarily recognized as a high-affinity probe for characterizing the structure and function of ADP-binding purinoceptors.

Other names
2-(Methylthio)adenosine 5'-diphosphate2-methylthio-ADP
02

Targets

P2RY13 (P2Y purinoceptor 13)P2Y12 (Purinergic P2Y12 receptor)P2RY1 (Purinergic Receptor P2Y1)

Beyond the preview

Go deeper on 2-methylthioadenosine 5'-diphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-methylthioadenosine 5'-diphosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call